Abstract
Recent progress in the study of atherosclerosis revealed that the proatherogenic property of LDL is attributable to oxidized LDL. Macrophages recruited to vascular wall phagocytose oxidized LDL and transformed into foam cells, which is a hallmark of atheroma. Endothelial cells also binds oxidized LDL and changes its phenotype to the status of "endothelial dysfunction." We successfully cloned the endothelial receptor for oxidized LDL, designated LOX-1. LOX-1-mediated action of oxidized LDL induces the decrease in NO release and the increased expression of adhesion molecules, which are typical changes in endothelial dysfunction. The expression of LOX-1 is quite inducible. Proinflammatory cytokines, etc. induce the expression of LOX-1 in vitro; and proatherogenic conditions, e.g., hypertension, hyperlipidemia, and diabetes, induce the expression of LOX-1 in vivo. This manner of expression suggests the importance of LOX-1 in pathological settings. LOX-1 binds not only oxidized LDL, but also binds apoptotic cells and activated platelets through the interaction with anionic phospholipids. This property might bridge atherosclerosis and thrombosis. A novel system to detect LOX-1 ligand in plasma detected the increased level of LOX-1 li...Continue Reading
References
Sep 14, 1990·Science·R GiordaM Trucco
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Apr 29, 1993·Nature·R Ross
Mar 6, 1997·Nature·T SawamuraT Masaki
Aug 28, 1997·Biochemical and Biophysical Research Communications·M NagaseT Fujita
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·K OkaT Masaki
Aug 26, 1998·Circulation Research·N KumeT Kita
Aug 26, 1998·Circulation Research·T MuraseT Kita
Nov 26, 1998·Genomics·S YamanakaH Iwao
Mar 23, 1999·The Biochemical Journal·T AoyamaT Masaki
May 15, 1999·Circulation Research·D Y LiJ L Mehta
Sep 1, 1999·Circulation·H MorawietzJ Holtz
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·M KakutaniT Sawamura
Jan 21, 2000·Journal of Molecular and Cellular Cardiology·T AoyamaT Sawamura
Mar 11, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·T MuraseT Kita
Apr 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·M ChenT Sawamura
Apr 25, 2000·The Journal of Biological Chemistry·L CominaciniT Sawamura
Jun 28, 2000·Circulation·D Li, J L Mehta
Oct 12, 2000·Biochemical and Biophysical Research Communications·H ChenJ L Mehta
Mar 10, 2001·Biochemical and Biophysical Research Communications·M NagaseT Fujita
Mar 27, 2001·Biochemical and Biophysical Research Communications·M KakutaniT Sawamura
Mar 30, 2001·The Journal of Biological Chemistry·L CominaciniT Sawamura
Apr 4, 2001·The Biochemical Journal·M ChenT Sawamura
Jun 21, 2001·Biochemical and Biophysical Research Communications·H MorawietzJ Holtz
Jun 26, 2001·FEBS Letters·M ChenT Sawamura
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·C L WelchA R Tall